+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pregabalin Market by Application (Epilepsy, Fibromyalgia, Generalized Anxiety Disorder), Dosage Form (Capsule, Oral Solution), Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Pregabalin Market by Application (Epilepsy, Fibromyalgia, Generalized Anxiety Disorder), Dosage Form (Capsule, Oral Solution), Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Pregabalin Market by Application (Epilepsy, Fibromyalgia, Generalized Anxiety Disorder), Dosage Form (Capsule, Oral Solution), Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666543
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global pregabalin market is undergoing significant transformation as pharmaceutical innovation, regulatory shifts, and changing patient needs reshape competitive positioning and growth pathways for brands and generics alike. Senior decision-makers require precise market intelligence to navigate this environment and craft value-driven strategies for sustainable success.

Market Snapshot: Pregabalin Market Size & Growth Outlook

The Pregabalin Market grew from USD 1.20 billion in 2024 to USD 1.30 billion in 2025. It is expected to continue expanding at a CAGR of 7.84%, reaching USD 1.90 billion by 2030.

Scope & Segmentation

This report delivers an in-depth assessment of the pregabalin market, analyzing product differentiation, regulatory drivers, cost dynamics, and strategic pathways across global regions.

  • Applications: Epilepsy, Fibromyalgia, Generalized Anxiety Disorder, Neuropathic Pain
  • Dosage Forms: Capsule, Oral Solution
  • Distribution Channels: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
  • End Users: Home Care Settings, Hospitals, Specialty Clinics
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Top Companies: Pfizer Inc., Viatris Inc., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, Sandoz International GmbH, Cipla Limited, Natco Pharma Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Limited, Hikma Pharmaceuticals PLC

Key Takeaways for Senior Decision-Makers

  • Broadening therapeutic applications of pregabalin, such as its expanded use in anxiety and neuropathic disorders, are driving renewed interest from prescribers and payers.
  • Generic entry following patent expirations is reshaping pricing models, increasing access while intensifying margin pressures—especially for smaller manufacturers with limited sourcing options.
  • Innovation in drug delivery platforms, including sustained-release and alternative oral solutions, is vital for improving patient adherence and enabling differentiated market offerings.
  • Digital health advancements, from telemedicine to patient apps, are being leveraged to enhance adherence and support remote monitoring, particularly in chronic therapies.
  • Regional disparities in regulatory frameworks and reimbursement policies demand market-specific entry and engagement strategies to optimize commercial outcomes.
  • Strategic alliances—including licensing, co-development, and contract manufacturing—support risk mitigation, access to new technologies, and operational efficiency in this evolving landscape.

PREGABALIN MARKET—Tariff Impact (2025 and Beyond)

Introduction of new US tariffs on active pharmaceutical ingredient imports in 2025 is altering cost structures across the pregabalin value chain. Manufacturers are reassessing supplier portfolios and pursuing near-shoring or regional manufacturing to reduce tariff exposure. Larger players are positioned to absorb incremental costs, while smaller firms face tighter margins and increased need for partnerships to ensure supply security and competitive pricing.

Methodology & Data Sources

This report integrates qualitative interviews with senior industry stakeholders and leading experts alongside systematic analysis of regulatory filings, clinical trial results, company disclosures, and competitive intelligence. Quantitative projections are validated through proprietary models incorporating adoption rates, cost inputs, and scenario testing to reflect potential market disruptions. Internal expert reviews further enhance data reliability and actionable insights.

Why This Report Matters

  • Empowers strategic planning by detailing critical shifts in pregabalin market dynamics, therapeutic trends, and evolving regulatory requirements.
  • Provides targeted analysis of key commercial challenges, technology innovations, and opportunities for risk mitigation across regional and segment-specific contexts.
  • Enables senior executives to benchmark against market leaders and optimize supply chain, pricing, and engagement strategies within a changing environment.

Conclusion

Stakeholders operating within the pregabalin ecosystem must respond to an evolving landscape shaped by innovation, regulation, and competitive intensity. Those who invest in operational agility, targeted differentiation, and collaborative partnerships will position themselves for sustainable growth and leadership in the market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Impact of generic pregabalin launches exerting pricing pressure across major markets
5.2. Innovation in extended-release pregabalin formulations targeting enhanced patient adherence
5.3. Emerging regulatory restrictions and anti-abuse scheduling affecting pregabalin availability
5.4. Growing demand for pregabalin in neuropathic pain segments amid aging population trends
5.5. Strategic partnerships between API producers and manufacturers to secure pregabalin supply
5.6. Adoption of digital health tools to monitor pregabalin therapy and mitigate misuse risk
5.7. Market expansion opportunities for pregabalin generics in developing Asia Pacific regions
5.8. Clinical research exploring novel indications of pregabalin beyond neuropathic pain management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pregabalin Market, by Application
8.1. Introduction
8.2. Epilepsy
8.3. Fibromyalgia
8.4. Generalized Anxiety Disorder
8.5. Neuropathic Pain
9. Pregabalin Market, by Dosage Form
9.1. Introduction
9.2. Capsule
9.3. Oral Solution
10. Pregabalin Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Pregabalin Market, by End User
11.1. Introduction
11.2. Home Care Settings
11.3. Hospitals
11.4. Specialty Clinics
12. Americas Pregabalin Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Pregabalin Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Pregabalin Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Pfizer Inc.
15.3.2. Viatris Inc.
15.3.3. Sun Pharmaceutical Industries Limited
15.3.4. Teva Pharmaceutical Industries Limited
15.3.5. Sandoz International GmbH
15.3.6. Cipla Limited
15.3.7. Natco Pharma Limited
15.3.8. Aurobindo Pharma Limited
15.3.9. Dr. Reddy’s Laboratories Limited
15.3.10. Hikma Pharmaceuticals PLC
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PREGABALIN MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PREGABALIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PREGABALIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PREGABALIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PREGABALIN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PREGABALIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PREGABALIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PREGABALIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PREGABALIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PREGABALIN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PREGABALIN MARKET: RESEARCHAI
FIGURE 24. PREGABALIN MARKET: RESEARCHSTATISTICS
FIGURE 25. PREGABALIN MARKET: RESEARCHCONTACTS
FIGURE 26. PREGABALIN MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PREGABALIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PREGABALIN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PREGABALIN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PREGABALIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PREGABALIN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PREGABALIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PREGABALIN MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PREGABALIN MARKET SIZE, BY EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PREGABALIN MARKET SIZE, BY FIBROMYALGIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PREGABALIN MARKET SIZE, BY FIBROMYALGIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PREGABALIN MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PREGABALIN MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PREGABALIN MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PREGABALIN MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PREGABALIN MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PREGABALIN MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PREGABALIN MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PREGABALIN MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PREGABALIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PREGABALIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PREGABALIN MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PREGABALIN MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PREGABALIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PREGABALIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PREGABALIN MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PREGABALIN MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PREGABALIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PREGABALIN MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PREGABALIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PREGABALIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. AMERICAS PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 42. AMERICAS PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 51. UNITED STATES PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 52. UNITED STATES PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 53. UNITED STATES PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 54. UNITED STATES PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 61. CANADA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 62. CANADA PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 63. CANADA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 64. CANADA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 65. CANADA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. CANADA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. CANADA PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. CANADA PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. MEXICO PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. MEXICO PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. MEXICO PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 72. MEXICO PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 73. MEXICO PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. MEXICO PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. MEXICO PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. MEXICO PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. BRAZIL PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. BRAZIL PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. BRAZIL PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 80. BRAZIL PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 81. BRAZIL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. BRAZIL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. BRAZIL PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. BRAZIL PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. ARGENTINA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. ARGENTINA PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. ARGENTINA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 88. ARGENTINA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 89. ARGENTINA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. ARGENTINA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. ARGENTINA PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. ARGENTINA PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED KINGDOM PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 106. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED KINGDOM PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. GERMANY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. GERMANY PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. GERMANY PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 114. GERMANY PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 115. GERMANY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. GERMANY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. GERMANY PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. GERMANY PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. FRANCE PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. FRANCE PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. FRANCE PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 122. FRANCE PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 123. FRANCE PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. FRANCE PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. FRANCE PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. FRANCE PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. RUSSIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. RUSSIA PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. RUSSIA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 130. RUSSIA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 131. RUSSIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. RUSSIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. RUSSIA PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. RUSSIA PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. ITALY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. ITALY PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. ITALY PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 138. ITALY PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 139. ITALY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. ITALY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. ITALY PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. ITALY PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. SPAIN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. SPAIN PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. SPAIN PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 146. SPAIN PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 147. SPAIN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. SPAIN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. SPAIN PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. SPAIN PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. SAUDI ARABIA PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 162. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. SAUDI ARABIA PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. SOUTH AFRICA PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 170. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. SOUTH AFRICA PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. DENMARK PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. DENMARK PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. DENMARK PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 178. DENMARK PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 179. DENMARK PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. DENMARK PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. DENMARK PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. DENMARK PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. NETHERLANDS PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. NETHERLANDS PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. NETHERLANDS PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 186. NETHERLANDS PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 187. NETHERLANDS PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. NETHERLANDS PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. NETHERLANDS PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. NETHERLANDS PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. QATAR PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. QATAR PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. QATAR PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 194. QATAR PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 195. QATAR PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. QATAR PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. QATAR PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. QATAR PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. FINLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. FINLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. FINLAND PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 202. FINLAND PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 203. FINLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. FINLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. FINLAND PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. FINLAND PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. SWEDEN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. SWEDEN PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. SWEDEN PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 210. SWEDEN PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 211. SWEDEN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. SWEDEN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. SWEDEN PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. SWEDEN PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. NIGERIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. NIGERIA PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. NIGERIA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 218. NIGERIA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 219. NIGERIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. NIGERIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. NIGERIA PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. NIGERIA PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. EGYPT PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. EGYPT PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. EGYPT PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 226. EGYPT PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 227. EGYPT PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. EGYPT PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. EGYPT PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. EGYPT PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. TURKEY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. TURKEY PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. TURKEY PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 234. TURKEY PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 235. TURKEY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. TURKEY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. TURKEY PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. TURKEY PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. ISRAEL PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. ISRAEL PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. ISRAEL PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 242. ISRAEL PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 243. ISRAEL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. ISRAEL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. ISRAEL PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. ISRAEL PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. NORWAY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. NORWAY PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. NORWAY PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 250. NORWAY PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 251. NORWAY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. NORWAY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. NORWAY PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. NORWAY PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. POLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. POLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. POLAND PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 258. POLAND PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 259. POLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. POLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. POLAND PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. POLAND PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. SWITZERLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. SWITZERLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. SWITZERLAND PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 266. SWITZERLAND PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 267. SWITZERLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. SWITZERLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. SWITZERLAND PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. SWITZERLAND PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 274. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 280. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 281. CHINA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. CHINA PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. CHINA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 284. CHINA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 285. CHINA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. CHINA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. CHINA PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. CHINA PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. INDIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. INDIA PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. INDIA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 292. INDIA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 293. INDIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. INDIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. INDIA PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. INDIA PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. JAPAN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. JAPAN PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. JAPAN PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 300. JAPAN PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 301. JAPAN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. JAPAN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. JAPAN PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. JAPAN PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. AUSTRALIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. AUSTRALIA PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. AUSTRALIA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 308. AUSTRALIA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 309. AUSTRALIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. AUSTRALIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. AUSTRALIA PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. AUSTRALIA PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. SOUTH KOREA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. SOUTH KOREA PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. SOUTH KOREA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 316. SOUTH KOREA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 317. SOUTH KOREA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. SOUTH KOREA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. SOUTH KOREA PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. SOUTH KOREA PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. INDONESIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. INDONESIA PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. INDONESIA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 324. INDONESIA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 325. INDONESIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. INDONESIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. INDONESIA PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. INDONESIA PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. THAILAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 330. THAILAND PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 331. THAILAND PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 332. THAILAND PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 333. THAILAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. THAILAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 335. THAILAND PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. THAILAND PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. PHILIPPINES PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 338. PHILIPPINES PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 339. PHILIPPINES PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 340. PHILIPPINES PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 341. PHILIPPINES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 342. PHILIPPINES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 343. PHILIPPINES PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. PHILIPPINES PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 345. MALAYSIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 346. MALAYSIA PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 347. MALAYSIA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 348. MALAYSIA PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 349. MALAYSIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 350. MALAYSIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 351. MALAYSIA PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 352. MALAYSIA PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 353. SINGAPORE PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 354. SINGAPORE PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 355. SINGAPORE PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 356. SINGAPORE PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 357. SINGAPORE PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 358. SINGAPORE PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 359. SINGAPORE PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 360. SINGAPORE PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 361. VIETNAM PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 362. VIETNAM PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 363. VIETNAM PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 364. VIETNAM PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 365. VIETNAM PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 366. VIETNAM PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 367. VIETNAM PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 368. VIETNAM PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 369. TAIWAN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 370. TAIWAN PREGABALIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 371. TAIWAN PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 372. TAIWAN PREGABALIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 373. TAIWAN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 374. TAIWAN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 375. TAIWAN PREGABALIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 376. TAIWAN PREGABALIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 377. PREGABALIN MARKET SHARE, BY KEY PLAYER, 2024
TABLE 378. PREGABALIN MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pregabalin market report include:
  • Pfizer Inc.
  • Viatris Inc.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Limited
  • Sandoz International GmbH
  • Cipla Limited
  • Natco Pharma Limited
  • Aurobindo Pharma Limited
  • Dr. Reddy’s Laboratories Limited
  • Hikma Pharmaceuticals PLC

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.3 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.9 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Pregabalin - Global Strategic Business Report - Product Image

Pregabalin - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Pregabalin Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Pregabalin Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 130 Pages
  • Global
From
Pregabalin (CAS 148553-50-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Pregabalin (CAS 148553-50-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Neuropathic Pain Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Neuropathic Pain Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 130 Pages
  • Global
From
Neuropathic Pain Drug Market by Product Type (Anticonvulsants, Antidepressants, Opioids), Route Of Administration (Intravenous, Oral, Topical), Indication, Distribution Channel - Global Forecast 2025-2030 - Product Image

Neuropathic Pain Drug Market by Product Type (Anticonvulsants, Antidepressants, Opioids), Route Of Administration (Intravenous, Oral, Topical), Indication, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From

About the Pregabalin Market

Pregabalin is a drug used to treat a variety of conditions related to the central nervous system, including epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. It is a gamma-aminobutyric acid (GABA) analog that works by binding to certain calcium channels in the brain, reducing the release of neurotransmitters that can cause pain and anxiety. Pregabalin is available in both oral and injectable forms, and is often prescribed in combination with other medications. Pregabalin is a relatively new drug, having been approved by the US Food and Drug Administration in 2004. Since then, it has become a popular treatment option for many conditions related to the central nervous system. It is generally well-tolerated and has fewer side effects than other drugs used to treat similar conditions. Some of the companies in the Pregabalin market include Pfizer, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.